Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

[1]  M. Jain,et al.  Externalized Glycolytic Enzymes Are Novel, Conserved, and Early Biomarkers of Apoptosis* , 2012, The Journal of Biological Chemistry.

[2]  Nick Tyler,et al.  Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[3]  A. Feldman,et al.  Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts , 2007, Gene Therapy.

[4]  G. Dangas,et al.  Cardiovascular morbidity and mortality of the metabolic syndrome. , 2007, The Medical clinics of North America.

[5]  Y. Yoshioka,et al.  TERT promoter-driven adenovirus vector for cancer gene therapy via systemic injection. , 2007, Biochemical and biophysical research communications.

[6]  Douglas Losordo,et al.  Therapeutic myocardial angiogenesis. , 2007, Microvascular research.

[7]  Ke-shu Xu,et al.  Axon guidance cue Netrin-1 has dual function in angiogenesis , 2007, Cancer biology & therapy.

[8]  J. Feijen,et al.  Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[9]  J. Feijen,et al.  Reducible poly(amido ethylenimine) directed to enhance RNA interference. , 2007, Biomaterials.

[10]  Y. Rui-xing,et al.  Intramyocardial injection of vascular endothelial growth factor gene improves cardiac performance and inhibits cardiomyocyte apoptosis , 2007, European journal of heart failure.

[11]  E. Wagner,et al.  Cell and Tissue Targeting of Nucleic Acids for Cancer Gene Therapy , 2007, Pharmaceutical Research.

[12]  Sung Wan Kim,et al.  Intracellular Kinetics of Non-Viral Gene Delivery Using Polyethylenimine Carriers , 2007, Pharmaceutical Research.

[13]  G. Wood,et al.  Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction , 2007, Biotechnology and bioengineering.

[14]  N. Ishii,et al.  Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression. , 2007, International journal of molecular medicine.

[15]  H. Katus,et al.  Targeting the heart with gene therapy-optimized gene delivery methods. , 2007, Cardiovascular research.

[16]  L. Brodin,et al.  Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model. , 2007, Cardiovascular research.

[17]  Soo Hyun Lee,et al.  PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[18]  M. Ogris,et al.  Reversibly stable thiopolyplexes for intracellular delivery of genes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[19]  D. Oupický,et al.  Multiblock reducible copolypeptides containing histidine-rich and nuclear localization sequences for gene delivery. , 2006, Bioconjugate chemistry.

[20]  E. Wagner,et al.  pH-responsive shielding of non-viral gene vectors , 2006, Expert opinion on drug delivery.

[21]  M. Ozelo,et al.  Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  G. Hortobagyi,et al.  A nonreplicating adenoviral vector that contains the wild‐type p53 transgene combined with chemotherapy for primary breast cancer , 2006, Cancer.

[23]  T. Park,et al.  Intracellular delivery of poly(ethylene glycol) conjugated antisense oligonucleotide using cationic lipids by formation of self-assembled polyelectrolyte complex micelles. , 2006, Journal of nanoscience and nanotechnology.

[24]  J. Feijen,et al.  Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. , 2006, Bioconjugate chemistry.

[25]  Chi-Bin Chien,et al.  Netrins Promote Developmental and Therapeutic Angiogenesis , 2006, Science.

[26]  G. Bray,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[27]  J. Feijen,et al.  A versatile family of degradable non-viral gene carriers based on hyperbranched poly(ester amine)s. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Yuichi Yamasaki,et al.  Supramolecular assemblies for the cytoplasmic delivery of antisense oligodeoxynucleotide: polyion complex (PIC) micelles based on poly(ethylene glycol)-SS-oligodeoxynucleotide conjugate. , 2005, Biomacromolecules.

[29]  G. Zuber,et al.  Monomolecular DNA nanoparticles for intravenous delivery of genes. , 2005, Journal of the American Chemical Society.

[30]  Ann Logan,et al.  A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids , 2005, Nucleic acids research.

[31]  K. Kataoka,et al.  Smart Polyion Complex Micelles for Targeted Intracellular Delivery of PEGylated Antisense Oligonucleotides Containing Acid‐Labile Linkages , 2005, Chembiochem : a European journal of chemical biology.

[32]  P. Ferruti,et al.  New poly(amidoamine)s containing disulfide linkages in their main chain , 2005 .

[33]  Sung Wan Kim,et al.  Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Jaroslav Pelisek,et al.  Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  F. Giancotti,et al.  Netrin-Integrin Signaling in Epithelial Morphogenesis, Axon Guidance and Vascular Patterning , 2005, Cell cycle.

[36]  G. Gurtner,et al.  Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. , 2005, Trends in cardiovascular medicine.

[37]  F. Szoka,et al.  Low‐pH‐sensitive poly(ethylene glycol) (PEG)‐stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery , 2005, The journal of gene medicine.

[38]  Dean Y. Li,et al.  The axonal attractant Netrin-1 is an angiogenic factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Reineke,et al.  New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. , 2004, Journal of the American Chemical Society.

[40]  Yuichi Yamasaki,et al.  Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. , 2004, Journal of the American Chemical Society.

[41]  Minhyung Lee,et al.  Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarction. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[43]  A. Bernkop‐Schnürch,et al.  Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[44]  K. Kataoka,et al.  pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. , 2003, Biomacromolecules.

[45]  F. Sellke,et al.  Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF. , 2003, American journal of physiology. Heart and circulatory physiology.

[46]  D. Bull,et al.  Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium , 2003, Gene Therapy.

[47]  R. Duncan,et al.  Poly(amido‐amine)s: Biomedical Applications , 2002 .

[48]  Wenjin Guo,et al.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. , 2001, Bioconjugate chemistry.

[49]  S. W. Kim,et al.  Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  V. Torchilin,et al.  Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[51]  R. Duncan,et al.  Poly(amidoamine)s as potential nonviral vectors: ability to form interpolyelectrolyte complexes and to mediate transfection in vitro. , 2001, Biomacromolecules.

[52]  E. Ikonen,et al.  How cells handle cholesterol. , 2000, Science.

[53]  D. Scherman,et al.  Reduction-sensitive lipopolyamines as a novel nonviral gene delivery system for modulated release of DNA with improved transgene expression. , 2000, Journal of medicinal chemistry.

[54]  G. Schoehn,et al.  Lipoic acid-derived amphiphiles for redox-controlled DNA delivery. , 2000, Chemistry & biology.

[55]  R. Duncan,et al.  Amphoteric Linear Poly(amido-amine)s as Endosomolytic Polymers: Correlation between Physicochemical and Biological Properties , 2000 .

[56]  Y. Kako,et al.  Lipoprotein Lipase-mediated Selective Uptake from Low Density Lipoprotein Requires Cell Surface Proteoglycans and Is Independent of Scavenger Receptor Class B Type 1* , 2000, The Journal of Biological Chemistry.

[57]  D. Lauffenburger,et al.  Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. , 2000, Biotechnology and bioengineering.

[58]  T. Anchordoquy,et al.  Physical stability of nonviral plasmid-based therapeutics. , 2000, Journal of pharmaceutical sciences.

[59]  E Marshall,et al.  Gene Therapy Death Prompts Review of Adenovirus Vector , 1999, Science.

[60]  Z. Szilvássy,et al.  Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. , 1999, Circulation.

[61]  A. Mikos,et al.  Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. , 1999, Journal of biomedical materials research.

[62]  D. Gill,et al.  A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis , 1997, Gene Therapy.

[63]  V. Torchilin,et al.  Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium. , 1996, Biochimica et biophysica acta.

[64]  L. Sartore,et al.  Recent results on functional polymers and macromonomers of interest as biomaterials or for biomaterial modification. , 1994, Biomaterials.

[65]  W. Kolch,et al.  Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. , 1994, Oncogene.

[66]  E. Nabel,et al.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. Hug,et al.  Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. , 1992, Cancer research.

[68]  V. Torchilin,et al.  Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain. , 1991, The American journal of physiology.

[69]  L. Huang,et al.  A novel cationic liposome reagent for efficient transfection of mammalian cells. , 1991, Biochemical and biophysical research communications.

[70]  J. Dietschy,et al.  Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. , 1983, Journal of lipid research.

[71]  V. Torchilin,et al.  Preservation of antimyosin antibody activity after covalent coupling to liposomes. , 1979, Biochemical and biophysical research communications.

[72]  E. Haber,et al.  Localization of cardiac myosin-specific antibody in myocardial infarction. , 1976, The Journal of clinical investigation.

[73]  D. Bull,et al.  Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct , 2009, Gene Therapy.

[74]  P. Boekstegers,et al.  Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors , 2008, Gene Therapy.

[75]  J. Feijen,et al.  Novel bioreducible poly(amido amine)s for highly efficient gene delivery. , 2007, Bioconjugate chemistry.

[76]  T. Reineke,et al.  Poly(glycoamidoamine)s for gene delivery. structural effects on cellular internalization, buffering capacity, and gene expression. , 2007, Bioconjugate chemistry.

[77]  You Han Bae,et al.  pH-responsive sulfonamide/PEI system for tumor specific gene delivery: an in vitro study. , 2006, Biomacromolecules.

[78]  T. Reineke,et al.  Poly(glycoamidoamine)s for Gene Delivery: Stability of Polyplexes and Efficacy with Cardiomyoblast Cells , 2006 .

[79]  Douglas Losordo,et al.  Non-viral vectors for gene therapy: clinical trials in cardiovascular disease. , 2005, Advances in genetics.

[80]  V. Torchilin,et al.  ATP-containing immunoliposomes specific for cardiac myosin. , 2004, Current drug delivery.

[81]  E. Wagner.  Strategies to Improve DNA Polyplexes for in Vivo Gene Transfer: Will “Artificial Viruses” Be the Answer? , 2004, Pharmaceutical Research.

[82]  S. W. Kim,et al.  Biodegradable Polyester, Poly[α-(4-Aminobutyl)-l-Glycolic Acid], as a Non-Toxic Gene Carrier , 2004, Pharmaceutical Research.

[83]  E. Delain,et al.  Poly[Lys-(AEDTP)]: a cationic polymer that allows dissociation of pDNA/cationic polymer complexes in a reductive medium and enhances polyfection. , 2002, Bioconjugate chemistry.

[84]  M. Garnett,et al.  Gene-delivery systems using cationic polymers. , 1999, Critical reviews in therapeutic drug carrier systems.

[85]  A. Rolland.  From genes to gene medicines: recent advances in nonviral gene delivery. , 1998, Critical reviews in therapeutic drug carrier systems.